What AI says about Addition Therapeutics
Addition Therapeutics is a company developing PRINT technology to create RNA therapeutics for rare, life-threatening diseases.
AI mentioned Addition Therapeutics from January 2026 to August 2026.
Questions and answers
- Most mentioned
- What are the latest affordable advancements in biopharma for treating rare diseases?U.S. Food and Drug Administration (FDA) shares the lead for mentions with 6 more
Excerpts where Addition Therapeutics appeared in the AI's answer
Addition Therapeutics in AI answers
What are the latest affordable advancements in biopharma for treating rare diseases?
Sites AI cites
None of these answers cited additiontx.com. AI cited linkedin.com, pmc.ncbi.nlm.nih.gov, and advi.com.
Brands AI mentions
AI mentioned Addition Therapeutics alongside Carnegie Mellon University, FDA Rare Disease Innovation Hub, and Rare Ventures.
For agents: this page as Markdown, https://parse.gl/brands/additiontx-com.md. JSON, MCP · free to read, $0.01 a check
This page
Ask and search
{"subject": "additiontx.com"}Connect
An agent can start a workspace with no account: POST https://agent.parse.gl/v1/workspaces
What it costs
Prices: https://parse.gl/pricing.md
Map of the site: https://parse.gl/llms.txt
